Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2026 ,inter alia, to consider and approve Update on board meeting ....
PGHL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Procter & Gamble Health Ltd has updated its earlier intimation about the Board Meeting scheduled on February 6, 2026. In addition to the original agenda, the Board will now also consider the declaration of an interim dividend for the financial year 2025-26. This revision was filed on January 21, 2026, supplementing the original intimation dated December 26, 2025. The company has informed both BSE (Scrip Code: 500126) and NSE (Scrip Code: PGHL) about this update.
Shareholders can expect a likely interim dividend announcement post the Board meeting on February 6, 2026. This is generally positive for income-focused investors, though the actual quantum and timing will only be known after the Board decision. No record date or dividend amount has been disclosed yet.